Financial statements Pharmavene
Balance sheet of Pharmavene
Company age:
Age:
6 y. 1 m. 25 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of PHARMAVENE
|
Year
|
2021
|
2022
|
|---|---|---|
| Total assets | 5 097 862,57 | 4 360 347,23 |
| A. Fixed assets | 694 346,88 | 1 166 268,02 |
| B. Current assets | 4 403 515,69 | 3 194 079,21 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 5 097 862,57 | 4 360 347,23 |
| A. Equity | 525 189,36 | 1 231 272,23 |
| B. Liabilities and provisions for liabilities | 4 572 673,21 | 3 129 075,00 |
| I. Long-term liabilities | - | - |
| II. Short-term liabilities | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.